Pharmaceutical
Engineering
Chemicals

Cambrex

$44.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-0.44%) As of 10:49 AM EDT today
-$0.20 (-0.44%) Today

Why Robinhood?

You can buy or sell Cambrex and other stocks, options, ETFs, and crypto commission-free!

About CBM

Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Read More Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.

Employees
1,732
Headquarters
East Rutherford, New Jersey
Founded
1981
Market Cap
1.51B
Price-Earnings Ratio
19.27
Dividend Yield
0.00
Average Volume
183.57K
High Today
$44.94
Low Today
$44.71
Open Price
$44.91
Volume
22.85K
52 Week High
$69.43
52 Week Low
$33.80

Collections

Pharmaceutical
Engineering
Chemicals
Therapy
Health
US
North America

CBM Earnings

$0.32
$0.69
$1.07
$1.44
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.